Incidence of cytomegalovirus (CMV) infection in allogeneic hematopoietic stem cell recipients at low risk of CMV infection
- 1 June 2002
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 29 (12) , 1005-1006
- https://doi.org/10.1038/sj.bmt.1703588
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment‐related mortality in stem cell transplantation from unrelated donors using pretransplantin vivoT‐cell depletion with anti‐thymocyte globulinBritish Journal of Haematology, 2001
- High frequency of positive surveillance for cytomegalovirus (CMV) by PCR in allograft recipients at low risk of CMVBone Marrow Transplantation, 2001
- Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplantsJournal of Clinical Virology, 2001
- Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantationBone Marrow Transplantation, 2000
- Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma.The Journal of Infectious Diseases, 1997
- PLASMA POLYMERASE CHAIN REACTION FOR CYTOMEGALOVIRUS DNA AFTER ALLOGENEIC MARROW TRANSPLANTATIONTransplantation, 1997